in this issue
Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients
Pharma/Fine Chemicals Roundup – July 24
1:37 PM MDT | July 24, 2012 | Deepti Ramesh, Sotirios Frantzanas, and Vincent Valk
NOVASEP EXPANDS HPAPI MANUFACTURING FACILITY IN FRANCE Novasep (Pompey, France) says it will expand its highly potent active pharmaceutical ingredients (HPAPIs) manufacturing capabilities at the company's Le Mans, France, facility. The investment is €3 million ($3.7 million). The plant's expansion is expected to be fully operational by the beginning of 2013, the company says. EUROPEAN API SALES TO REACH $38.25 BILLION BY 2017 The total revenue generated by the European active pharmaceutical ingredient (API) market was $26.28 billion in 2011 and is expected...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee